Physician profile
Matt D Roth
NPI 1457566101
$1,602.83
in general payments reported to CMS, 2019-2025
19 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $228 · 2021: $82.79 · 2022: $227 · 2023: $141 · 2024: $132 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $635.90 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $199.39 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $177.16 | 2019-2022 | |
| Lilly USA, LLC | $66.76 | 2019-2023 | Mounjaro |
| Exact Sciences Corporation | $63.63 | 2023-2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $62.82 | 2019-2021 | |
| Glaxosmithkline, LLC. | $55.71 | 2019-2023 | Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.16 | 2019-2025 | Jardiance |
| Abbott Laboratories | $41.00 | 2022-2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $35.44 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $34.75 | 2023-2024 | Exparel, Zilretta, Iovera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.78 | 2022 | |
| Sanofi-Aventis U.S. LLC | $27.87 | 2019 | |
| Amgen INC. | $27.80 | 2019-2025 | Repatha |
| Amarin Pharma, INC. | $23.72 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $21.83 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.18 | 2023 | |
| Daiichi Sankyo INC. | $18.26 | 2020 | |
| Corium, LLC | $14.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matt Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.